Showing results (51-60 of 57) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Brain Sciences|February 25, 2022
Olfactory Dysfunction, Headache, and Mental Clouding in Adults with Long-COVID-19: What Is the Link between Cognition and Olfaction? A Cross-Sectional StudyArianna Di Stadio, Michael J Brenner, Pietro De Luca, et al.Life (Basel, Switzerland)|January 21, 2023
Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)?Arianna Di Stadio, Evanthia Bernitsas, Ignazio La Mantia, et al.Annals of Neurology|July 30, 2026
Two Years of Ocrelizumab Treatment in Black and Hispanic People with Multiple Sclerosis in CHIMES: A Single-Arm Clinical TrialLilyana Amezcua, Anthony T Reder, Evanthia Bernitsas, et al.Diagnostics (Basel, Switzerland)|January 21, 2022
A Comparison of Magnetic Resonance Imaging Methods to Assess Multiple Sclerosis Lesions: Implications for Patient Characterization and Clinical Trial DesignEwart Mark Haacke, Evanthia Bernitsas, Karthik Subramanian, et al.Multiple Sclerosis and Related Disorders|June 25, 2023
Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trialMitzi J Williams, Annette F Okai, Anne H Cross, et al.Journal of Neurology|November 15, 2022
Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectivesPenny Pennington, Bianca Weinstock-Guttman, Channa Kolb, et al.JAMA Neurology|February 18, 2020
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical TrialJames F Howard, Richard J Nowak, Gil I Wolfe, et al.Pageof 6